Zobrazeno 1 - 10
of 856
pro vyhledávání: '"Zörnig M"'
Autor:
George, Tina P.1 (AUTHOR), Subramanian, Suja2 (AUTHOR) sujasubramanian@gmail.com, Supriya, M. H.2 (AUTHOR)
Publikováno v:
Egyptian Journal of Medical Human Genetics. 9/2/2024, Vol. 25 Issue 1, p1-16. 16p.
Autor:
Baumgarten, P, Harter, PN, Tönjes, M, Capper, D, Blank, AE, Schwamb, B, Rabenhorst, U, Kögel, D, Rieker, RJ, Plate, KH, Ohgaki, H, Radlwimmer, B, Zörnig, M, Mittelbronn, M
Publikováno v:
57th Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN); 20120912-20120915; Erlangen; DOC12dgnnPP3.14 /20120911/
The Far Upstream Element [FUSE] Binding Protein 1 (FUBP1) regulates target genes, such as the cell cycle regulators MYC and p21. FUBP1 is upregulated in many solid tumors and functions as an oncoprotein by stimulating proliferation and inhibiting apo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c05cb4fa20a369fc4696fad66f6e6523
Autor:
Atlı, Muharrem1 muharrematli@gmail.com, Çetin, Sema1, Oguztuzun, Serpil1, Başak, Kayhan2, Aydın, Sedat3, Kardiyen, Filiz4, Demir, Mehmet Gökhan3, Yılmaz, Can5
Publikováno v:
Southern Clinics of Istanbul Eurasia. Jun2024, Vol. 35 Issue 2, p191-195. 5p.
Autor:
Khan, Mohd Mabood1 (AUTHOR) mohd.m.khan@vumc.org, Kirabo, Annet1 (AUTHOR) mohd.m.khan@vumc.org
Publikováno v:
International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5507. 18p.
The transcriptional regulator FUBP1 influences disease outcome in murine and human myeloid leukemia.
Autor:
Hoang VT; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Verma D; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Godavarthy PS; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Llavona P; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Steiner M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Gerlach K; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Michels BE; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biological Sciences, Goethe University Frankfurt, Frankfurt, Germany., Bohnenberger H; Universitätsmedizin Göttingen, Institute of Pathology, Georg-August-Universität, 37075, Göttingen, Germany., Wachter A; Universitätsmedizin Göttingen, Department of Medical Statistics, Georg-August-Universität, 37075, Göttingen, Germany., Oellerich T; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; University Hospital Frankfurt, Department of Medicine II, Hematology/Oncology, Frankfurt, Germany., Müller-Kuller U; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Weissenberger E; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Voutsinas JM; Fred Hutchinson Cancer Research Center, Clinical Research Division, Biostatistics, Seattle, WA, USA., Oehler VG; Fred Hutchinson Cancer Research Center, Clinical Research Division, Division of Hematology, University of Washington Medical Center, Seattle, WA, USA., Farin HF; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Zörnig M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Krause DS; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany. Krause@gsh.uni-frankfurt.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. Krause@gsh.uni-frankfurt.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. Krause@gsh.uni-frankfurt.de.; Faculty of Medicine, Johann Wolfgang Goethe University, Frankfurt, Germany. Krause@gsh.uni-frankfurt.de.
Publikováno v:
Leukemia [Leukemia] 2019 Jul; Vol. 33 (7), pp. 1700-1712. Date of Electronic Publication: 2019 Jan 11.
Autor:
Cui H; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Banerjee S; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Guo S; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Department of Pulmonary, Allergy, and Critical Care Medicine, The Second Affiliated Hospital, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Xie N; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Ge J; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Department of Geriatrics and Institute of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Jiang D; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases, Beijing, China., Zörnig M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany., Thannickal VJ; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Liu G; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Publikováno v:
JCI insight [JCI Insight] 2019 Feb 21; Vol. 4 (4). Date of Electronic Publication: 2019 Feb 21 (Print Publication: 2019).
Autor:
Steiner M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany., Schneider L; Institute for Transfusion Medicine and Immunohematology, Goethe-University and German Red Cross Blood Service, Frankfurt am Main, Germany., Yillah J; Institute for Transfusion Medicine and Immunohematology, Goethe-University and German Red Cross Blood Service, Frankfurt am Main, Germany., Gerlach K; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany., Kuvardina ON; Institute for Transfusion Medicine and Immunohematology, Goethe-University and German Red Cross Blood Service, Frankfurt am Main, Germany., Meyer A; Institute for Transfusion Medicine and Immunohematology, Goethe-University and German Red Cross Blood Service, Frankfurt am Main, Germany., Maring A; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany., Bonig H; Institute for Transfusion Medicine and Immunohematology, Goethe-University and German Red Cross Blood Service, Frankfurt am Main, Germany., Seifried E; Institute for Transfusion Medicine and Immunohematology, Goethe-University and German Red Cross Blood Service, Frankfurt am Main, Germany., Zörnig M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt/Main, Germany., Lausen J; Institute for Transfusion Medicine and Immunohematology, Goethe-University and German Red Cross Blood Service, Frankfurt am Main, Germany.
Publikováno v:
PloS one [PLoS One] 2019 Jan 17; Vol. 14 (1), pp. e0210515. Date of Electronic Publication: 2019 Jan 17 (Print Publication: 2019).
Autor:
Debaize L; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France., Jakobczyk H; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France., Avner S; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France., Gaudichon J; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France., Rio AG; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France., Sérandour AA; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44035 Nantes, France.; Ecole Centrale de Nantes, Nantes, France., Dorsheimer L; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany., Chalmel F; Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France., Carroll JS; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK., Zörnig M; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, D-60528 Frankfurt, Germany., Rieger MA; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany., Delalande O; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France., Salbert G; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France., Galibert MD; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France.; Génétique Somatique des Cancers, Centre Hospitalier Universitaire, 35033 Rennes, France., Gandemer V; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France.; Department of pediatric oncohematology, Centre Hospitalier Universitaire, 35203 Rennes, France., Troadec MB; Univ Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, F-35000 Rennes, France.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2018 Nov 30; Vol. 46 (21), pp. 11214-11228.
Autor:
Kramer, D., Schön, M., Bayerlová, M., Bleckmann, A., Schön, M. P., Zörnig, M., Dobbelstein, M.
Publikováno v:
Cell Death & Disease
The p53 family and its cofactors are potent inducers of apoptosis and form a barrier to cancer. Here, we investigated the impact of the supposedly inhibitory member of the apoptosis-stimulating protein of p53, iASPP, on the activity of the p53 homolo